These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29227418)

  • 21. Persistent disparities in SARS-CoV-2 test percent positivity by neighborhood in New York City, March 1-July 25, 2020.
    Chan PY; Greene SK; Lim SW; Fine A; Thompson CN
    Ann Epidemiol; 2021 Nov; 63():46-51. PubMed ID: 34391928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disparities in community viral load among HIV-infected persons in New York City.
    Laraque F; Mavronicolas HA; Robertson MM; Gortakowski HW; Terzian AS
    AIDS; 2013 Aug; 27(13):2129-39. PubMed ID: 24384591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular Carcinoma and Viral Hepatitis in New York City.
    Moore MS; Ivanina E; Bornschlegel K; Qiao B; Schymura MJ; Laraque F
    Clin Infect Dis; 2016 Dec; 63(12):1577-1583. PubMed ID: 27585801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the prevalence of hepatitis C infection in New York City using surveillance data.
    Balter S; Stark JH; Kennedy J; Bornschlegel K; Konty K
    Epidemiol Infect; 2014 Feb; 142(2):262-9. PubMed ID: 23657093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deaths among people with hepatitis C in New York City, 2000-2011.
    Pinchoff J; Drobnik A; Bornschlegel K; Braunstein S; Chan C; Varma JK; Fuld J
    Clin Infect Dis; 2014 Apr; 58(8):1047-54. PubMed ID: 24523215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geographic epidemiology of hepatocellular carcinoma, viral hepatitis, and socioeconomic position in New York City.
    Ford MM; Ivanina E; Desai P; Highfield L; Qiao B; Schymura MJ; Laraque F
    Cancer Causes Control; 2017 Jul; 28(7):779-789. PubMed ID: 28573469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale, design and respondent characteristics of the 2013-2014 New York City Health and Nutrition Examination Survey (NYC HANES 2013-2014).
    Thorpe LE; Greene C; Freeman A; Snell E; Rodriguez-Lopez JS; Frankel M; Punsalang A; Chernov C; Lurie E; Friedman M; Koppaka R; Perlman SE
    Prev Med Rep; 2015; 2():580-5. PubMed ID: 26844121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. False-positive oral fluid rapid HIV tests--New York City, 2005-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(24):660-5. PubMed ID: 18566566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notes from the Field: Increase in Reported Hepatitis A Infections Among Men Who Have Sex with Men - New York City, January-August 2017.
    Latash J; Dorsinville M; Del Rosso P; Antwi M; Reddy V; Waechter H; Lawler J; Boss H; Kurpiel P; Backenson PB; Gonzalez C; Rowe S; Poissant T; Lin Y; Xia GL; Balter S
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(37):999-1000. PubMed ID: 28934181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Public Health Approach to Hepatitis C in an Urban Setting.
    Laraque F; Varma JK
    Am J Public Health; 2017 Jun; 107(6):922-926. PubMed ID: 28426310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Impact of Mandating Health Care Providers to Offer Hepatitis C Virus Screening to All Persons Born During 1945-1965 - New York, 2014.
    Flanigan CA; Leung SJ; Rowe KA; Levey WK; King A; Sommer JN; Morne JE; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2017 Sep; 66(38):1023-1026. PubMed ID: 28957037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the prevalence of chronic hepatitis B virus infection--New York City, 2008.
    France AM; Bornschlegel K; Lazaroff J; Kennedy J; Balter S
    J Urban Health; 2012 Apr; 89(2):373-83. PubMed ID: 22246675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011.
    Pinchoff J; Tran OC; Chen L; Bornschlegel K; Drobnik A; Kersanske L; Fuld J
    Epidemiol Infect; 2016 Dec; 144(16):3354-3364. PubMed ID: 27510414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers to Treatment Among New York City Residents with Chronic Hepatitis C Virus Infection, 2014.
    King A; Bornschlegel K; Johnson N; Rude E; Laraque F
    Public Health Rep; 2016; 131(3):430-7. PubMed ID: 27252563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study design and participation rates of the New York City Health and Nutrition Examination Survey, 2004.
    Thorpe LE; Gwynn RC; Mandel-Ricci J; Roberts S; Tsoi B; Berman L; Porter K; Ostchega Y; Curtain LR; Montaquila J; Mohadjer L; Frieden TR
    Prev Chronic Dis; 2006 Jul; 3(3):A94. PubMed ID: 16776895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variations in Healthcare Provider Use of Public Health and Other Information Sources by Provider Type and Practice Setting During New York City's Response to the Emerging Threat of Zika Virus Disease, 2016.
    Quinn C; Poirot E; Sanders Kim A; Viswanath AL; Patel SN; Abramson DM; Piltch-Loeb R
    Health Secur; 2018; 16(4):252-261. PubMed ID: 30133373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013.
    Jordan AE; Des Jarlais DC; Arasteh K; McKnight C; Nash D; Perlman DC
    Drug Alcohol Depend; 2015 Jul; 152():194-200. PubMed ID: 25891230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C surveillance among youth and young adults in New York City, 2009-2013.
    Prussing C; Bornschlegel K; Balter S
    J Urban Health; 2015 Apr; 92(2):387-99. PubMed ID: 25450518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost Comparison Between 2 Responses to Hepatitis A Virus Incidents in Restaurant Food Handlers-New York City, 2015 and 2017.
    Baum SE; Reddy V; Vora NM; Balter S; Daskalakis D; Barbot O; Misener M; Rakeman J; Rojas J; Starr D; Waechter H; Zucker J; Lee D
    J Public Health Manag Pract; 2020; 26(2):176-179. PubMed ID: 31995548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.